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BACKGROUND: Automated analysis of cardiac structure and function 
using machine learning (ML) has great potential, but is currently hindered 
by poor generalizability. Comparison is traditionally against clinicians as 
a reference, ignoring inherent human inter- and intraobserver error, and 
ensuring that ML cannot demonstrate superiority. Measuring precision 
(scan:rescan reproducibility) addresses this. We compared precision of ML 
and humans using a multicenter, multi-disease, scan:rescan cardiovascular 
magnetic resonance data set.
METHODS: One hundred ten patients (5 disease categories, 5 
institutions, 2 scanner manufacturers, and 2 field strengths) underwent 
scan:rescan cardiovascular magnetic resonance (96% within one week). 
After identification of the most precise human technique, left ventricular 
chamber volumes, mass, and ejection fraction were measured by an 
expert, a trained junior clinician, and a fully automated convolutional 
neural network trained on 599 independent multicenter disease cases. 
Scan:rescan coefficient of variation and 1000 bootstrapped 95% CIs were 
calculated and compared using mixed linear effects models.
RESULTS: Clinicians can be confident in detecting a 9% change in left 
ventricular ejection fraction, with greater than half of coefficient of 
variation attributable to intraobserver variation. Expert, trained junior, and 
automated scan:rescan precision were similar (for left ventricular ejection 
fraction, coefficient of variation 6.1 [5.2%–7.1%], P=0.2581; 8.3 [5.6%–
10.3%], P=0.3653; 8.8 [6.1%–11.1%], P=0.8620). Automated analysis 
was 186× faster than humans (0.07 versus 13 minutes).
CONCLUSIONS: Automated ML analysis is faster with similar precision to 
the most precise human techniques, even when challenged with real-
world scan:rescan data. Assessment of multicenter, multi-vendor, multi-
field strength scan:rescan data (available at www.thevolumesresource.
com) permits a generalizable assessment of ML precision and may 
facilitate direct translation of ML to clinical practice.
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Left ventricular ejection fraction (LVEF) and mass (LVM) remain key imaging biomarkers and are used daily for clinical decision-making and as clinical trial 
outcome measures.1,2 Absolute values guide pharma-
cotherapy, device therapy, and surgical intervention. 
Although it is important that measurement is accurate 
against some putative reference- or at least that any bias 
is known, it is measurement precision (repeatability) that 
determines the clinical smallest detectable difference 
with time or treatment and the sample size of clinical tri-
als.3 Cardiovascular magnetic resonance (CMR) imaging 
is the reference standard imaging modality to assess LV 
structure and function, and image acquisition is largely 
standardized through international consensus guide-
lines.4 In contrast, there is less agreement about analysis 
techniques where significant variation exists between 
inclusion/exclusion of papillary muscles, trabeculae, and 
use of edge detection methods despite the CMR com-
munity desire for consistency and precision.
LVEF and LVM measurement variation arise from 
many sources including on-target changes with disease 
or intervention, off-target unavoidable biological varia-
tion (eg, heart rate and volume status), and avoidable 
intraobserver, inter-observer, inter-study, inter-center 
variation. These include noise (eg, intraobserver varia-
tion) and bias (one observer may systematically detect 
an edge differently to another),5,6 but relative contribu-
tions of each error source are not known.
Training programs and semi-automated contour-
ing speed up segmentation and improve inter-observer 
agreement, but techniques vary considerably.7–9 Auto-
mated analysis via machine learning (ML) approaches 
using deep learning neural networks show potential,10,11 
and could remove this intra- and inter-observer variation. 
Currently, ML algorithms are tested by direct comparison 
with human expert observers as the reference standard, 
however this ignores sources of human error and means 
that ML techniques are unable to demonstrate superiority 
over human techniques. Precision can only be assessed 
using a test:retest data set- this requires a significant sized 
patient cohort to be scanned twice in an identical fash-
ion within an interval short enough to effectively exclude 
variation in disease biology.5,12,13 For generalizability, this 
should be done across multiple sites and platforms.
A multi-scanner, multicenter, health and disease preci-
sion (scan-rescan) CMR data set resource for use as a tool 
to measure human and ML LVEF, and LVM analysis perfor-
mance was collated. This resource was then used to quan-
tify CMR precision and different sources of human error 
(scan acquisition, observer experience, level of automation) 
using multiple analysis techniques. Having understood 
error sources from human approaches, a deep learning 
convolutional neural network was trained on a large multi-
scanner multicenter disease cohort and explored human 
and ML performance. It was hypothesized that greater cli-
nician experience and semi-automated contouring would 
improve human precision, and that an automated tech-
nique would have superior performance overall.
METHODS
Data Availability
The authors declare that all supporting data are available 
within the article and its in the Data Supplement. Details 
of scan-rescan data set availability are at www.thevolumes-
resource.com (Validation Of Left ventricular Myocardial and 
Endocardial Segmentation resource), intended for those wish-
ing to benchmark future automated analysis approaches.
Study Population
The scan-rescan CMR parameters for precision assessment 
are outlined in Table I in the Data Supplement. In brief, paired 
scans were obtained from 5 United Kingdom institutions (Barts 
CLINICAL PERSPECTIVE
Left ventricular ejection fraction and mass remain 
key imaging biomarkers and are used daily for clini-
cal decision-making and as clinical trial outcome 
measures. While cardiovascular magnetic resonance 
imaging to measure left ventricular ejection fraction 
is performed at high resolution, clinician analy-
sis is remarkably variable. Automated techniques 
using machine learning may offer time-saving and 
improved confidence in absolute values, but they 
should be demonstrably generalizable and pre-
cise (repeatable) before widespread adoption. To 
address this, a multicenter, multi-vendor, multi-field 
strength, multi-disease cardiovascular magnetic res-
onance resource of 110 patients undergoing repeat 
imaging in a short time-frame was assembled. This 
was analyzed by an expert, a trained junior clinician 
(using five different techniques), and a fully auto-
mated convolutional neural network. This showed 
that clinicians can be confident in detecting a 
9% change in left ventricular ejection fraction or 
a 20 g change in LV mass. This will be difficult to 
improve for clinicians because the greatest source 
of human error was attributable to the observer 
rather than modifiable factors. Having understood 
these errors, a convolutional neural network was 
trained on separate multicentre data for automated 
analysis and was successfully generalizable to the 
real-world cardiovascular magnetic resonance data. 
Precision was similar to human analysis, and perfor-
mance was 186× faster. Automated cardiovascular 
magnetic resonance analysis should, therefore, be 
adopted globally to gain from time-saving and stan-
dardization benefits. The real-world benchmarking 
resource has been made available, detailed at www.
thevolumesresource.com.
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Heart Centre, University Hospitals Bristol, Leeds Teaching 
Hospitals, University College London Hospital, and University 
Hospitals Birmingham NHS Trusts) with 6 different MRI scan-
ners of 2 field strengths (1.5T, 3T), 2 manufacturers (Siemens, 
Philips), and 3 models (Aera, Achieva, Avanto) representing 
the clinical spectrum (health, dilatation, hypertrophy, regional 
disease, n=118). Each institution obtained local approval via 
the United Kingdom National Research Ethics Service; the 
study conformed to the principles of the Helsinki Declaration, 
and all subjects gave written informed consent. Inclusion cri-
teria were patients over age 18 years undergoing CMR with 
balanced steady-state free precession cine imaging on 2 occa-
sions within a time-frame where biological change was not 
anticipated. Scans:rescans were acquired either both before 
or after gadolinium based contrast administration, using 
the same protocol, as per the international guidelines on 
scan acquisition.4 Scans acquired on the same day involved 
removing the patient from the table and performing repeat 
isocenter positioning. Exclusion criteria included patients with 
a cardiac implantable electronic device, significant arrhythmia 
(atrial fibrillation or ectopy) during the scan, claustrophobia 
or inability to breath-hold. Allometric data were collected 
before the scan, and body surface area (BSA) was calculated 
using the Mosteller formula, Height x Weight
3600
1/2


 . Diagnoses 
were provided by the recruiting center.
CMR Scan-Rescan and Intraobserver 
Reproducibility
Each data set consisted of cine imaging in at least 2 long-axis 
orientations and a complete short-axis stack. Both scans per 
patient were assigned separate, randomly generated, 4-digit 
identification codes for blinded scan and rescan assessment. 
The first scan was also duplicated and assigned a separate 
identification code for assessment of blinded intraobserver 
reassessment. Data sets were excluded (n=8) if there were 
missing slices or unacceptable quality on one or other acquisi-
tion judged by an expert observer (Dr Moon).
Clinician Analysis
Images were analyzed by an expert (Dr Moon) with greater 
than 15 years experience and 2 cardiology trainees (Drs Ye 
and Lau) with less than one year of experience reporting 
CMR. With 5 human analysis techniques, variation in per-
formance was expected. A 3 stage process was therefore 
designed, Figure 1.
Stage One
Two trainees undertook a training/standardization program 
over one month. Both were initially Society of Cardiovascular 
Magnetic Resonance level 1 accredited, and they had con-
toured ≈100 and 700 scans with senior clinicians respectively 
for the 2 observers. Contouring feedback was provided by 2 
experts (Drs Moon and Manisty) and standardized instructions 
created (consensus—based on local practice and informed by 
known international standard operating procedures within 
UK Biobank and MESA),14—see tutorial video and standard 
operating procedures in Methods in the Data Supplement. 
Fifteen (different) studies ranging in difficulty were contoured 
and then recontoured a month later to assess training impact.
Stage Two
The 2 trainees each analyzed 10 scan-rescans of patients rep-
resenting different pathologies using 5 techniques (total 200 
complete LVs contoured; Methods in the Data Supplement 
and Figure  2). Techniques were (1) free-hand fully manual 
contouring; (2) visual thresholding of the blood-myocardial 
Figure 1. Flow diagram illustrating study 
recruitment and analysis.  
Shaded blue boxes represent study outcome 
measures. *Missing slices or significant breath-
ing artifact on one scan.
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border; (3) curve fitting between points on the endocardium 
(click-draw); (4) level-set segmentation initialized by a mid-
myocardial contour; and (5) semi-automated contouring 
after manual centering of the LV blood-pool. To minimize the 
impact of learning, at least 24 hours were left between analy-
sis using the separate techniques, and scans were analyzed in 
a random order for each technique.
Stage Three
This transitioned the most precise technique from stage 2 for 
both the expert and trainees to analyze the entire data set 
of 110 patients (scan A, scan B, blinded scan A again). This 
totaled 330 LV volumes by expert; 330 by trainees—by this 
time the trainees were indistinguishable in performance so 
they acted as one observer, dividing work; and 330 by the 
automated neural network). Analysis time was measured for 
a sample of 50 scans for one trainee and for all automated 
analyses.
All analyses took place using a bespoke prototype of CVI42 
(Release 5.3.8 [720], Circle, Calgary, Canada) to include a 
novel level-set segmentation technique previously developed 
and implemented for fractal analysis and modified in this 
study for endocardial contouring.15 End diastolic (ED) and end 
systolic (ES) phases were defined as the largest and smallest 
long-axis ventricular volumes visually. Contiguous short-axis 
slices were delineated in ED (endocardium first then epicar-
dium) and ES (endocardium) to derive LV end diastolic volume 
(EDV), end systolic volume (ESV), stroke volume (SV), ejection 
fraction (LVEF) and LVM, with allometric scaling using body 
surface area. To address basal slice variability, blood volume 
was included if there was over 50% of LV myocardium sur-
rounding blood-pool, and a long-axis atrioventricular plane 
correction was used. The left ventricular outflow tract was 
included in the blood volume.
Automated Neural Network Training  
and Analysis
An automated 2-dimensional deep fully convolutional neu-
ral network was previously developed to predict LV endo-
cardial and epicardial contours at ED and ES from an input 
CMR steady-state free precession short-axis stack.10 The 
network was previously trained on 4875 subjects from the 
UK Biobank, however performance was not easily general-
izable to multicenter, multi-disease data. So, the network 
was trained from scratch on 599 multicenter, multi-scanner 
data sets of patients with severe aortic stenosis, as described 
elsewhere.16 Although this cohort represents one primary 
disease, extensive comorbidity (hypertension ≈53%, diabetes 
mellitus ≈22%, coronary artery disease ≈29%), and the ven-
tricular response (≈50% with focal scar, ≈60% with hyper-
trophy [3 different subtypes], ≈20% with impairment) made 
it representative of human cardiac disease in general. These 
599 scans (comprising ≈13 cines, each 25 frames 195 000 
images) were annotated at ED and ES by an expert observer 
(Dr Moon). Annotations were performed after the standard-
ized post-processing guidelines above. Papillary muscles and 
trabeculations were included in the LV blood-pool. Training 
of the network took 8 hours 40 minutes on a Nvidia Titan X 
GPU.
Statistics
Data were analyzed in R (R foundation, Vienna, Austria) using 
RStudio Server version 0.98 (Boston, Mass). All continuous 
variables are expressed as mean±SD or median (interquartile 
range) for skewed data. Categorical variables are expressed as 
frequencies in percent. Multiple groups were compared using 
one-way ANOVA.
For inter-observer agreement, an intraclass correlation 
coefficient (Lin's concordance correlation coefficient) was 
used which reflects both agreement and deviation from 
the line of perfect concordance; <0.2=poor, >0.8=excellent 
agreement.17
To quantify reproducibility, 3 metrics were used: the abso-
lute difference between scans, Bland-Altman limits of agree-
ment, and within-subject Coefficient of variation (CV).18 The 
within-subject variance was bootstrapped (1000 bootstraps) 
to estimate a 95% CI of the CV.
For a head-to-head comparison of scan-rescan precision 
between techniques or operators, linear mixed effects regres-
sion models were used, which account for multiple observ-
ers analyzing multiple measures per subject. Models were run 
separately for each LV metric (EDV, ESV, SV, LVEF, or LVM) as 
the dependent variable. To assess training, the dependent 
variable was the difference between expert and trainee, and 
the fixed effect was training category (before/after). To assess 
technique, the dependent variable was the LV metric, and the 
fixed effects were technique and scan-rescan category (1 or 
2). An interaction between technique and scan category was 
used to assess scan-rescan precision for each technique.19 To 
assess different operators, the dependent variable was the LV 
metric, and the fixed effects were operator, scan-rescan cat-
egory and the interaction term of operator and scan-rescan 
Figure 2. Manual and semi-automated techniques used to segment the endocardial border.  
From left to right segmentation techniques become increasingly semi-automated: fully manual; visual signal intensity-based thresholding; manual point series; mid-
myocardial contour to initialize level-set segmentation; and blood-pool centering to initialize semi-automated segmentation.
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category. To assess the effect of LV impairment, a fixed effect 
of Scan 1 LVEF was included. Random effects included study 
subject in all models and operator when assessing training 
and effect of semi-automated technique.
Sample size required to detect a clinical change was cal-
culated from the standardized difference (d) in each LV metric 
with a power of 90% and α of 0.05, where d is the desired clin-
ical change divided by the SD of scan-rescan differences. The 
SE of measurement was calculated as the square root of the 
mean squared error obtained from one-way ANOVA. The mini-
mal detectable change between 2 scans considered to be dif-
ferent was calculated as 2×SE of measurement. All tests were 
2-tailed, and P<0.05 was considered statistically significant.
RESULTS
Scan-Rescan Cohort
The final data set of 110 scan-rescans represented 
patients with myocardial infarction (n=32), left ven-
tricular hypertrophy (n=17, including hypertrophic 
cardiomyopathy), cardiomyopathy (n=17, dilated, 
arrhythmogenic right ventricular and left ventricular 
noncompaction cardiomyopathies), other pathology 
(n=14, cardio-oncology follow-up and chronic kidney 
disease), and healthy volunteers (n=30). All LV metrics 
differed significantly between diagnostic sub-groups, 
Table  1. One hundred six rescans (96%) were per-
formed within one week (82% on the same day); 4 
scans in healthy volunteers were performed between 1 
week and 3 months.
Impact of Initial Training on Trainee-
Expert Agreement
Training and implementation of a standard operating 
procedure significantly improved agreement between 
trainees and an expert for all LV metrics, Table II in the 
Data Supplement.
Impact of Techniques on Human Accuracy 
(Bias) and Precision
The thresholding and semi-automated techniques did 
not show a difference in accuracy with reference to 
manual contouring. As expected, the other 2 tech-
niques showed over/under-estimation in EDV, ESV, and 
LVM; but not LVEF or SV: the click-draw technique mea-
sured the LV as larger and showed a trend to lower 
LVM (EDV 6.0±2.9 mL, P=0.0449; ESV 5.0±2.0 mL, 
P=0.0133; and LVM −6.7±3.6 g, P=0.0671); the level-
set technique measured the LV as smaller and LVM as 
higher (EDV −8.3±2.9 mL, P=0.0056; ESV −5.8±2.0 
mL, P=0.0042); LVM 15±4.3 g, P<0.0004).
For precision, however, there was no significant dif-
ference between techniques for either observer, Table III 
in the Data Supplement. This included both techniques 
that included papillary muscles in the blood-pool and 
those that included them within the myocardial mass, 
Figure  2. Given the similar precision between tech-
niques, subsequent analysis of the complete data set 
by the expert and trainee used the thresholding tech-
nique, because it showed fewer large mistakes requir-
ing manual correction.
Expert, Trainee and Automated Accuracy 
(Bias), Precision and Speed
There was good agreement between expert and train-
ee (intraclass correlation coefficients, 0.92–0.98) and 
automated analysis (intraclass correlation coefficients, 
0.90–0.98) for all LV metrics, Figures I and II in the 
Data Supplement. Compared with expert analysis, 
trainee analysis measured the LV as slightly smaller, 
and LVEF and LVM as slightly higher. Automated analy-
sis, conversely, measured the LV as slightly larger, and 
LVEF and LVM as slightly lower, Table IV in the Data 
Supplement.
Table 1. Study Participant Characteristics
Patient Characteristics
Myocardial 
Infarction
Left Ventricular 
Hypertrophy Cardiomyopathy Other Pathology Healthy Volunteers P Value
No. 32 17 17 14 30  
Male 26 (81%) 14 (82%) 9 (53%) 5 (36%) 22 (73%) -
BSA, m2 1.94±0.4 1.99±0.4 2.00±0.4 1.88±0.5 1.82±0.5 -
Age, y 60±11 60±12 49±13 50±15 31±9 <0.0001
LVMi, g per m2 77±22 92±19 93±33 61±16 61±10 <0.0001
EDVi, mL per m2 75±22 73±15 122±45 76±23 88±13 <0.0001
ESVi, mL per m2 34±17 24±7 72±51 28±13 33±9 <0.0001
SVi, mL per m2 41±9 49±12 49±12 48±12 55±7 <0.0001
EF, % 56±8 68±8 45±17 64±7 63±5 <0.0001
Patients with left ventricular hypertrophy had diagnoses of hypertrophic cardiomyopathy (n=11), aortic stenosis (n=3), hypertensive heart disease (n=2), 
Anderson-Fabry disease (n=1). Patients with other cardiomyopathies had diagnoses of dilated cardiomyopathy (n=13), arrhythmogenic right ventricular 
cardiomyopathy (n=1), and left ventricular noncompaction (n=3). Other pathologies include chronic renal failure (n=5) and patients under cardio-oncology 
follow-up (n=9). Groups were compared using one-way ANOVA. BSA indicates body surface area; EDVi, (indexed) end diastolic volume; EF, ejection fraction; ESVi, 
(indexed) end systolic volume; LVMi, (indexed) left ventricular mass; and SVi, (indexed) stroke volume.
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For precision, however, there was no significant dif-
ference between expert, trainee and automated analy-
sis for all LV metrics, Table V in the Data Supplement. 
Table  2 and Figure  3 detail scan-rescan and intraob-
server differences, Bland-Altman limits of agreement, 
and CV.
Human analysis time was 13  (interquartile range, 
9–19) minutes per scan. Automated analysis time of a 
25-phase short-axis stack was ≈0.07 minutes.
Sources of Error for Human and 
Automated Techniques
Average human CV for intraobserver, inter-observer 
and scan-rescan reproducibility were, for LVEF: 5.3%, 
6.3%, and 7.2%, and for LVM: 4.6%, 7.6%, and 
5.5% respectively, Figure  4 and Figure  5. For all LV 
metrics, human intraobserver CV was greater than 
half of the scan-rescan CV. For humans, scan-rescan 
CV was the greatest source of error for EDV, ESV, SV, 
and LVEF, while inter-observer error was the greatest 
source of error for LVM, Table VI in the Data Supple-
ment. For automated analysis, there was zero intraob-
server error as this technique was nonstochastic, that 
is, with the same image, the network would always 
generate an identical result. For all observers, preci-
sion was not influenced by the degree of impairment 
in LVEF.
Sample Size Estimates and Minimal 
Detectable Change
Calculation of sample size from these data shows 
that CMR requires 28 patients to detect a 3% change 
in LVEF; 12 patients to detect a 10 g change in LVM; 
and 17, 10, and 16 patients to detect a 10 mL 
change in EDV, ESV, and SV, respectively, Table 3. The 
percentage change in sample size of an expert for 
all LV metrics was similar to a trainee (×1.2–1.5) and 
automated analysis (×0.8–1.5). Sample size require-
ments were largest for patients with left ventricular 
hypertrophy.
For an individual patient, the minimal detectable 
change was 8.7% in LVEF or 20 g in LVM, based on 
expert analysis (with no difference when compared 
with automated analysis).
DISCUSSION
Despite reliance on measurements of LVEF and LVM for 
clinical decision-making and as end points in research 
studies, analysis is often not standardized and the 
relative contributions of error sources are imperfectly 
known. These data show that using current standard-
ized image acquisition and multicenter, multi-vendor, 
multi-field strength, multi-disease, scan-rescan data at 
scale, measurement error was largely due to inconsis-
tency in the human observer rather than variation in 
modifiable factors- clinician experience, scan acquisi-
tion, or human contour strategy (here performed using 
5 techniques). This study also demonstrated for the 
first time that an automated analysis technique using 
deep learning has equivalent precision (scan-rescan 
reproducibility) to an expert, and yielded ≈13 minutes 
time-saving per scan, tested head-to-head on variable 
pathologies from multiple institutions. Clinicians can be 
confident in detecting a 9% change in LVEF or a 20 g 
change in LVM, this was similar if using an automated 
ML technique. Because the resource has the potential 
to test superiority of automated over human analysis, 
Figure 3. Scan-rescan coefficient of varia-
tion for expert, trainee, and automated 
neural network analysis.  
All comparisons are not significant (Table V in 
the Data Supplement ). EDV indicates left ven-
tricular end diastolic volume; EF, left ventricular 
ejection fraction ESV, left ventricular end systolic 
volume; and SV, left ventricular stroke volume.
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scan-rescan data and training videos/standard operat-
ing procedures have been made available.
Previous studies investigating LV analysis by CMR 
have largely focused on inter-observer and intrao-
bserver differences, usually using data sets from 
healthy individuals in single centers.5,6 Clinical prac-
tice relies on scan-rescan precision, and includes 
sources of variation not previously captured in most 
data sets such as the scan acquisition, differences 
between institution, and disease states. This study 
looked at the efficacy of a number of potential strat-
egies (decided a priori) that might reduce or main-
tain variability with time-saving through automation: 
clinician experience, training, human contouring 
methods, and deployment of an automated neural 
network segmentation approach.
Benefits of Automated Analysis
The adoption of ML can offer comparable precision 
with clinicians, with the time saving and global stan-
dardization that would ensue. Training of junior cli-
nicians required a month-long program, compared 
with ≈9 hours for a neural network. Once trained, 
clinicians required an average of 13 minutes for analy-
sis per scan, compared with ≈4 seconds for a neu-
ral network. In the UK, an estimated 2275 scans per 
million adults are needed annually, performed in 61 
centers.20 Automating this one aspect of CMR analy-
sis alone would, therefore, potentially translate into a 
saving of 54 clinician-days per center. Accurate auto-
mated segmentation is a bridge to reliable extraction 
of more information from the same imaging beyond 
Figure 4. Examples of different contours for one cardio-oncology patient.  
Analysis is by 3 observers (rows) over 3 data sets (columns), with average analysis timing per scan per observer reported. Left column: original scan 1, middle 
column: blinded scan 1 re-analysis; right column: repeat scan 2. Note this is one phase of one slice of ≈10 in each short-axis stack; that all human contours differ 
whereas the automated neural network scan 1 blinded reanalysis contours are identical. Note also the similar position but different piloting and orientation of the 
repeat scan 2.
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established imaging biomarkers. In combination with 
time saving, this maximizes use of acquired data in a 
value-based manner.
ML Techniques can Surpass Human 
Precision
Given that the greatest sources of measurement error 
were human factors (ie, nonmodifiable intra- and inter-
observer variability), we believe that, with improvement, 
it is only a matter of time before automated approach-
es are super-human, with cascading consequences in 
clinical (confidence, smallest detectable difference) 
and research (trial size) domains of increased precision. 
Improvement could be related to either training data 
or the network itself, and comparison of scan-rescan 
precision against that of an expert offers the ability to 
show superior performance, and provides an important 
validation step towards real-world scalability.
Similar performance of automated techniques to 
humans has previously been shown by comparing 
the degree of inter-observer agreement between 2 
clinicians and clinician-network agreement in typi-
cally healthy subjects.10,11 Evaluation of new auto-
mated segmentation techniques is typically performed 
against expert ground truth in medical imaging grand 
challenge data sets, and presented as contour com-
parisons (such as mean error or dice index).21,22 Expert 
segmentation for the ground truth comparisons is 
time consuming meaning cases numbers are neces-
sarily small, limited to a few centers and pathologies, 
and such metrics are not intuitive for clinicians.6 UK 
Biobank data and the MICCAI ACDC 2017 challenge 
have addressed issues of cohort size and differences 
between scanners, but using this approach it is not 
possible to identify a technique that is superior to 
human analysis, despite growing appreciation of the 
high intra- and inter-observer variability in human 
measurements.6,10,11 Comparison of measurement pre-
cision between techniques using test:retest method-
ology avoids this limitation, and this cohort enables 
identification of methods that are both generalizable 
and superior to humans.
Superior performance will require potentially larger 
and more variable pathology datasets facilitated by 
adversarial training, or transfer learning.23,24 How-
ever, if training is performed by one expert annotat-
ing each dataset, neural networks will be trained to 
minimize between subject differences, but not dif-
ferences between or within observers. Training on 
repeated measures may minimize these errors. This 
could also be surmounted by the use of stronger pri-
ors,25 3D neural networks or even limiting the reliance 
on annotation through deeper, more intelligent pixel 
classification.
Neural network approaches, however, do show 
limitations. Data must be standardized before analy-
sis, and neural networks are computationally expensive 
to train and require clinician-facing interfaces before 
widespread implementation. Biologically implausible 
segmentations are also possible and therefore results 
require human review.11
Sample Size Estimates
This study provides benchmark precision metrics that 
reflect a range of pathologies and institutions. Required 
sample sizes to detect a standardized difference was 
greatest for patients with left ventricular hypertrophy 
who had increased LVM and small systolic cavity vol-
umes. The sample size required to detect a clinically 
important change was between 10 and 28 patients for 
different LV metrics, which is higher than previous esti-
mates.5,12,13 This data set however is different due to 
its high variability, and should these results be consid-
ered for future study design, there may be reasons that 
these results either over- or under-represent anticipated 
performance for a specific real-world task. Factors that 
make precision higher here include: excellent training/
Figure 5. Contributions of intra-, inter-observer, and scan-rescan error 
to human measurement variability.  
For ejection fraction, human error (coefficient of variation) is incremental from 
intraobserver, inter-observer (on the same scan), to inter-scan. For mass, hu-
man inter-observer error is greatest. Scan-rescan error is similar for human and 
automated neural network analysis, however the majority of error for human 
analysis is related to the observer suggesting that automated techniques have 
other sources that can be addressed to surpass human performance. Human 
error is the average of both human observers.
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standardization and operator selection; bias from using 
only the best 110 studies from 118 with (by definition) 
no further dropout; scan-rescan at short time intervals; 
a few expert centers only. Factors that make precision 
lower here include: inclusion of multiple diseases; mul-
tiple centers; multiple scanners and blinded analysis. 
While follow-up studies may be analyzed consecutively 
in clinical practice, we ensured that the 2 scans acquired 
for each subject were assigned different randomized 
study numbers to minimize bias in this study. There was 
no review of study data at study completion, with all 
analyzed data sets included in the results.
Sources of Human Measurement Error
It is generally accepted that there is incremental varia-
tion from intraobserver, inter-observer and scan-rescan 
(physiological and technical) differences.26 These data 
Table 2. Scan-Rescan and Intraobserver Reproducibility Stratified by Observer
Scan-Rescan Reproducibility Intraobserver Reproducibility
EDV, mL ESV, mL SV, mL EF (%) Mass, g EDV, mL ESV, mL SV, mL EF (%) Mass, g
Expert
 Mean 159±51 69±46 90±23 59±12 142±44 160±51 69±45 91±24 59±12 143±44
 Difference 9±8 6±6 9±8 4±3 7±7 5±4 5±5 6±5 3±3 4±3
 CV/% 5.7  
(4.7–6.8)
10.0  
(8.1–11.8)
9.4  
(7.8–11.0)
6.1  
(5.2–7.1)
4.8  
(4.1–5.6)
3.1  
(2.5–3.7)
7.4  
(6.1–8.9)
6.4  
(5.1–7.8)
5.4  
(3.9–6.9)
3.8  
(3.25–4.29)
 BA limits −23 to 26 −18 to 17 −20 to 25 −9 to 10 −19 to 19 −12.5 to 12.2 −13 to 13 −16 to 15 −8 to 8 −16 to 15
Trainee
 Mean 156±51 64±47 92±26 61±14 146±45 157±51 64±45 92±26 61±13 144±43
 Difference 10±9 7±7 1 0±9 5±4 9±8 5±6 5±5 6±6 3±3 8±7
 CV/% 7.0  
(5.8–8.2)
13.8  
(11.4–16.2)
11.7  
(9.4–13.9)
8.3 
(5.6–10.3)
6.1 
(5.2–6.9)
3.6
(2.9–4.3)
9.6
(7.4–11.8)
6.8
(5.5–8.2)
5.2
(4.2–6.2)
5.5
(4.2–6.7)
 BA limits −25 to 29 −19 to 20 −25 to 28 −12 to 12 −25 to 23 −15 to 16 −14 to 14 −17 to 18 −8 to 9 −22 to 20
Automated
 Mean 166±53 77±47 89±26 56±12 135±40 − − − − −
 Difference 10±9 8±8 10±9 4±4 6±6 − − − − −
 CV/ % 6.5
(5.2–7.8)
11.8
(8.5–14.6)
11.7
(9.1–14.1)
8.8
(6.1–11.1)
4.7
(4.0–5.6)
− − − − −
 BA limits −25 to 28 −22 to 20 −24 to 29 −11 to 12 −17 to 16 − − − − −
Data are presented as cohort mean±SD; absolute difference between scans±SD; CV and 95% CI; and BA limits. BA limits indicates Bland-Altman limits of 
agreement; CV, within-subject coefficient of variation; EDV, end diastolic volume; EF, ejection fraction; ESV, end systolic volume;  and SV, stroke volume.
Table 3. Sample Size Estimates Stratified by Observer and Pathology
Sample Size Estimates (n), α=0.05, 90% Power
EDV ESV SV EF Mass
10 mL change 10 mL change 10 mL change 3% change 10g change
SD n SD n SD n SD n SD n
Whole cohort
  Expert 12 17 9 10 11 16 5 28 10 12
  Trainee 14 ×1.3 10 ×1.2 14 ×1.3 6 ×1.5 12 ×1.5
  Automated 13 ×1.2 11 ×1.4 13 ×1.3 6 ×1.5 8 ×0.8
Sub-groups (expert only)
  MI 12 18 7 7 11 15 5 31 11 14
  LVH 13 20 9 11 13 20 5 36 8 9
  CM 12 17 10 12 9 10 4 19 13 20
  Other pathology 14 23 6 6 12 17 3 15 6 7
  HV 9 11 10 13 11 16 5 26 9 11
For Trainee and Automated neural network analysis, sample size is represented as a proportional change to Expert analysis. Sample size estimates stratified by 
pathology are presented for expert analysis only.
CM indicates cardiomyopathy; EDV, end diastolic volume; EF, ejection fraction; ESV, end systolic volume; HV, healthy volunteers; LVH, left ventricular 
hypertrophy; MI, myocardial infarction; SD, standard deviation; and SV, stroke volume.
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demonstrated that human (intraobserver) error (CV) 
was greater than half of scan-rescan error, an effect 
that was not minimized by an expert when compared 
with junior clinicians after appropriate training, despite 
15 years' additional experience. A training program 
combined with standard operating procedures was an 
effective approach to improve inter-observer agree-
ment, by standardizing basal blood volume and papil-
lary muscles, as previously reported.7,8 Semi-automated 
techniques, including a novel level-set approach with 
minimal user interaction also did not improve preci-
sion over manual techniques, a finding replicated in 2 
observers. However, human contour strategies resulted 
in potentially clinically relevant differences for an indi-
vidual patient, emphasizing the need to interpret refer-
ence ranges in the context of the technique from which 
they were derived.
To improve human measurement precision, an 
improved focus on unifying a systematic approach 
to analysis and greater acquisition standardization 
appears important. This would require investigating 
piloting of the short-axis cine stack, loading conditions, 
or sequence improvements that improve myocardial 
contrast with epicardial fat.27
Study Limitations
We measured variability using a relatively small num-
ber of observers, however by including both train-
ees and an international expert as the gold standard 
observer, the errors measured are likely to be repre-
sentative. Both scans for each patient were acquired 
in the same institution using the same protocol, and 
therefore we have not assessed scan-rescan precision 
between institutions. The scan-rescan interval was 
short (with 82% of studies acquired on the same day), 
and we are, therefore, unable to assess the contribu-
tion of physiological variability across months or years. 
The precision of right ventricular assessment was not 
within the scope of this study. We analyzed the per-
formance of a ML approach but not its prospective 
clinical application.
CONCLUSIONS
Automated ML techniques for LV analysis match human 
precision and perform substantially faster. Based on 
multicenter, multi-vendor, multi-field strength, multi-
disease data, a 9% change in ejection fraction can 
be detected confidently by expert clinicians, and this 
is similar using automated analysis. Given that a major 
source of measurement variability is attributable to the 
observer, automated approaches offer the future poten-
tial to surpass human experts, demonstrable using this 
scan-rescan resource.
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